Analystreport

NGM Biopharmaceuticals, Inc. (NYSE: NGM) had its price target raised by analysts at Smith Barney Citigroup from $28.00 to $44.00.

NGM Biopharmaceuticals, Inc.  (NGM) 
Last ngm biopharmaceuticals, inc. earnings: 3/17 04:05 pm Check Earnings Report